Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EyePoint, Inc.EYPT · Entity 5702 | SVP & Chief Commercial Officer | February 09, 2024 | February 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EyePoint, Inc.
Report date February 09, 2024 · Filed February 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 43,572 |
Reported balance
After 2024-02-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-02-09 · Exercise / conversion · Acquired 4,967 · Balance 43,572 F1: Includes 643 shares acquired on January 31, 2024 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. |
| Common StockSEC Table I · non-derivative | Direct | 48,572 |
Reported balance
After 2024-02-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2024-02-09 · Exercise / conversion · Acquired 5,000 · Balance 48,572 |
| Common StockSEC Table I · non-derivative | Direct | 46,617 |
Reported balance
After 2024-02-09 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2024-02-09 · Tax withholding · Disposed 1,955 · Balance 46,617 F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| Common StockSEC Table I · non-derivative | Direct | 44,916 |
Reported balance
After 2024-02-09 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2024-02-09 · Tax withholding · Disposed 1,701 · Balance 44,916 F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2031-02-09 | Direct | 0 |
Reported balance
After 2024-02-09 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2024-02-09 · Exercise / conversion · Disposed 4,967 · Balance 0 F3: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-02-09 | Direct | 5,000 |
Reported balance
After 2024-02-09 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2024-02-09 · Exercise / conversion · Disposed 5,000 · Balance 5,000 F4: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 643 shares acquired on January 31, 2024 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
F2: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units
F3: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022.
F4: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2024 Filed Feb 13, 2024 17:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001292 · primarydocument.xml · derivative · entry 6 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2032-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 17:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001292 · primarydocument.xml · derivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,967 shares Expires 2031-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 17:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,701 | $28.80 | $48,988.80 |
DisclosureSEC source: 0001562180-24-001292 · primarydocument.xml · nonDerivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,916 F2 · kind: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 17:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,955 | $28.80 | $56,304.00 |
DisclosureSEC source: 0001562180-24-001292 · primarydocument.xml · nonDerivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,617 F2 · kind: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 17:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001292 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 17:38 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 4,967 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001292 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,572 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 643 shares acquired on January 31, 2024 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 17:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 209 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001562180-24-001050 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,375 Underlying: Common Stock · 209 shares Expires 2031-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option to purchase vests and becomes exercisable as follows: 25% at November 1st, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 17:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 209 | $28.49 | $5,954.41 |
DisclosureSEC source: 0001562180-24-001050 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,962 Read SEC document |
| February 02, 2024 Filed Feb 5, 2024 17:15 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 209 | $11.47 | $2,397.23 |
DisclosureSEC source: 0001562180-24-001050 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,171 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 16,413 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-24-000785 · primarydocument.xml · derivative · entry 6 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,742 Underlying: Common Stock · 16,413 shares Expires 2033-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,604 | $0.00 Strike: $12.90 | $0.00 |
DisclosureSEC source: 0001562180-24-000785 · primarydocument.xml · derivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,721 Underlying: Common Stock · 9,604 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020 Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 9,604 | $25.27 | $242,717.09 |
DisclosureSEC source: 0001562180-24-000785 · primarydocument.xml · nonDerivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,962 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.00 to $25.88. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 16,413 | $25.45 | $417,653.40 |
DisclosureSEC source: 0001562180-24-000785 · primarydocument.xml · nonDerivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,566 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.00 to $26.00. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 16,413 | $3.26 | $53,506.38 |
DisclosureSEC source: 0001562180-24-000785 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2024 Filed Jan 29, 2024 17:54 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 9,604 | $12.90 | $123,891.60 |
DisclosureSEC source: 0001562180-24-000785 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · derivative · entry 12 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,155 Underlying: Common Stock · 300 shares Expires 2033-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option to purchase vests and becomes exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $12.90 | $0.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · derivative · entry 11 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,325 Underlying: Common Stock · 300 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020 Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 300 | $25.00 | $7,500.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 8 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,962 Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 300 | $25.00 | $7,500.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 7 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,262 Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 300 | $3.26 | $978.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 6 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 300 | $12.90 | $3,870.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 38,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,700 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · derivative · entry 10 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,455 Underlying: Common Stock · 5,700 shares Expires 2033-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option to purchase vests and becomes exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,600 | $0.00 Strike: $12.90 | $0.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · derivative · entry 9 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,625 Underlying: Common Stock · 5,600 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020 Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 5,600 | $25.01 | $140,067.76 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,962 F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.00 to $25.25. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 5,700 | $25.01 | $142,553.58 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,562 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.00 to $25.09. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,700 | $3.26 | $18,582.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,262 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 17:03 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,600 | $12.90 | $72,240.00 |
DisclosureSEC source: 0001562180-24-000673 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 500 | $0.00 Strike: $3.26 | $0.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · derivative · entry 12 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,155 Underlying: Common Stock · 500 shares Expires 2033-01-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option to purchase vests and becomes exercisable as follows: 25% at January 6th, 2024 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $12.90 | $0.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · derivative · entry 11 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,225 Underlying: Common Stock · 400 shares Expires 2030-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option to purchase vests and becomes exercisable ratably in forty-eight monthly installments which began March 28, 2020 Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 500 | $25.00 | $12,500.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 8 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,962 Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 400 | $25.00 | $10,000.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 7 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,462 Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 500 | $3.26 | $1,630.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 6 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,862 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 23, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 400 | $12.90 | $5,160.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 28,750 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · derivative · entry 10 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,250 Underlying: Common Stock · 28,750 shares Expires 2032-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at February 9th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,416 | $0.00 Strike: $11.47 | $0.00 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · derivative · entry 9 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,584 Underlying: Common Stock · 5,416 shares Expires 2031-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at November 1st, 2022 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 28,750 | $22.69 | $652,254.13 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,962 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $23.04. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | SaleCommon Stock | 5,416 | $22.24 | $120,437.22 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,712 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $23.00. The reporting person undertakes to provide EyePoint Pharmaceuticals Inc., any security holder of EyePoint Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,416 | $11.47 | $62,121.52 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,128 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 16:50 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 28,750 | $10.13 | $291,237.50 |
DisclosureSEC source: 0001562180-24-000581 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2024 Filed Jan 9, 2024 21:09 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 15,285 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000399 · primarydocument.xml · derivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,570 Underlying: Common Stock · 15,285 shares Expires 2033-06-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The restricted stock units vests in three ratable annual installments beginning January 6, 2024. Read SEC document |
| January 06, 2024 Filed Jan 9, 2024 21:09 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 4,147 | $20.40 | $84,598.80 |
DisclosureSEC source: 0001562180-24-000399 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,962 F2 · kind: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of his withholding right following the vesting of the restricted stock units Read SEC document |
| January 06, 2024 Filed Jan 9, 2024 21:09 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 15,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000399 · primarydocument.xml · nonDerivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,109 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,691 shares acquired on July 31, 2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:09 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantStock Option (Right to Buy) · Derivative | 42,000 | $0.00 Strike: $20.40 | $0.00 |
DisclosureSEC source: 0001562180-24-000399 · primarydocument.xml · derivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,000 Underlying: Common Stock · 42,000 shares Expires 2034-01-04 F4 · derivative.exercise_date: The option to purchase will vest and become exercisable as follows: 25% at January 5th, 2025 and the remainder ratably, on a monthly basis, over the remaining three years. Read SEC document |
| January 05, 2024 Filed Jan 9, 2024 21:09 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 21,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-000399 · primarydocument.xml · derivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2034-01-05 F3 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 5, 2025. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 09:16 UTC | EyePoint, Inc. EYPT · Entity 5702 | GrantRestricted Stock Units · Derivative | 45,855 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005444 · primarydocument.xml · derivative · entry 1 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,855 Underlying: Common Stock · 45,855 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. F1 · derivative.expiration_date: The restricted stock units will vest in three ratable annual installments beginning January 6, 2024. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 17:02 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 4,967 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001332 · primarydocument.xml · derivative · entry 6 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,967 Underlying: Common Stock · 4,967 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. F4 · derivative.expiration_date: The restricted stock units vest in three ratable annual installments beginning February 9, 2022. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 17:02 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionRestricted Stock Units · Derivative | 5,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001332 · primarydocument.xml · derivative · entry 5 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The restricted stock units vest in three annual installments beginning February 9, 2023. F3 · derivative.expiration_date: The restricted stock units vest in three annual installments beginning February 9, 2023. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 17:02 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,473 | $4.17 | $6,142.41 |
DisclosureSEC source: 0001562180-23-001332 · primarydocument.xml · nonDerivative · entry 4 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,133 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 17:02 UTC | EyePoint, Inc. EYPT · Entity 5702 | Tax withholdingCommon Stock | 1,483 | $4.17 | $6,184.11 |
DisclosureSEC source: 0001562180-23-001332 · primarydocument.xml · nonDerivative · entry 3 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,606 F2 · price: No shares were sold - these shares were withheld by the issuer to satisfy tax withholding requirements in connection with the Reporting Person's exercise of their withholding right following the vesting of the restricted stock units. Read SEC document |
| February 09, 2023 Filed Feb 13, 2023 17:02 UTC | EyePoint, Inc. EYPT · Entity 5702 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001332 · primarydocument.xml · nonDerivative · entry 2 Jones David Scott · CIK 0001779458 · SVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,089 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.